Novel Tricyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches

Key Points

• This research aims to explore novel tricyclic compounds as 5-HT2A receptor agonists for therapeutic uses.
• Developed new tricyclic compounds targeting 5-HT2A receptors.
• Formulated pharmaceutical compositions for clinical applications.
• Outlined processes for preparing these compounds.
• Identified several novel compounds with activity at the 5-HT2A receptor.
• Demonstrated potential efficacy for treating depression and anxiety.
• Showed promise in addressing substance abuse and headaches.